SS
FBRX icon

SBI Securities’s Forte Biosciences FBRX Stock Holding History

SBI Securities’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255 Hold
12
– – ﹤0.01% 3253
2026
Q1 		$311 Hold
12
– – ﹤0.01% 3063
2025
Q4 		$327 Sell
12
-1
-8% -$18 ﹤0.01% 3035
2025
Q3 		$195 Buy
13
+1
+8% +$12 ﹤0.01% 3322
2025
Q2 		$155 Hold
12
– – ﹤0.01% 3392
2025
Q1 		$93 Hold
12
– – ﹤0.01% 3464
2024
Q4 		$273 Buy
+12
New +$143 ﹤0.01% 3133

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

SBI Securities's FBRX Position: Q2 2026 in Review

SBI Securities held its Forte Biosciences (FBRX) position steady in Q2 2026 at 12 shares worth $255. The position accounts for ﹤0.01% of the portfolio, ranked #3253.

SBI Securities first reported a position in FBRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $327 in Q4 2025. 57 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • SBI Securities held 12 shares of Forte Biosciences worth $255 as of Q2 2026.
  • SBI Securities left its Forte Biosciences share count unchanged in Q2 2026.
  • Forte Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3253 holding.
  • SBI Securities first reported a position in Forte Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Forte Biosciences position peaked at $327 in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.